Medicine and Dentistry
Biological Marker
10%
Biopsy
8%
Cancer Staging
16%
Cell Marker
25%
Chronic Pancreatitis
50%
Computer Assisted Tomography
75%
Congenital Malformation
25%
Deep Vein Thrombosis
25%
down Regulation
8%
Effector Cell
8%
Endothelial Cell
25%
Esophageal Cancer
50%
Esophageal Squamous Cell Carcinoma
50%
Gene Expression
8%
Histopathology
25%
Immunocompetent Cell
8%
Immunotherapy
16%
Irreversible Electroporation
50%
Liver Metastasis
50%
Lower Limb
25%
Lymph Duct
25%
Neoplasm
8%
Neutrophil
8%
Overall Survival
8%
Pancreas Cancer
50%
Pancreatic Duct
20%
Patient-Data
16%
Pembrolizumab
16%
Plasmacytoid Dendritic Cell
8%
Podoplanin
25%
Programmed Death-Ligand 1
8%
Progression Free Survival
8%
Quantitative Imaging
20%
Scoring System
20%
T Cell
8%
Tumor Microenvironment
8%
Tumor Progression
8%
Upper Gastrointestinal Cancer
16%
Upregulation
8%
Keyphrases
Abdominal Girth
25%
Axial Plane
8%
Category Strategies
10%
Cavernous Malformation
25%
Curability
20%
Cyst Wall
25%
D2-40
25%
External Iliac Vessels
25%
Immune Stimulation
12%
Immune-suppressive
12%
Immune-suppressive
8%
Inflammation-related Proteins
12%
Lymphatic Markers
25%
Multi-observer
50%
Multidisciplinary Team Conference
50%
New Scoring System
8%
Operability Assessment
10%
PD-L1 Inhibition
8%
Perfect Observers
10%
Quantitative Imaging Biomarkers
8%
Retroperitoneal Cyst
50%
Sequential Biopsy
8%
Stromal Tissue
25%
Team Assessment
50%
TNM Categories
20%
Tumor Resectability
10%
Vascular Origin
25%
Immunology and Microbiology
Cytokine
12%
Downregulation
8%
Effector Cell
20%
Electroporation
100%
Gene Expression
8%
Immunity
50%
Immunocompetent Cell
20%
Immunotherapy
41%
Myeloid-Derived Suppressor Cell
8%
Neutrophil Granulocyte
8%
Overall Survival
8%
Pembrolizumab
66%
Plasmacytoid Dendritic Cell
20%
Preclinical Study
20%
Programmed Death-Ligand 1
8%
Progression Free Survival
8%
T Cell
20%
Upregulation
8%